Evidence map›Paper›PMID 25226386›Full record

ArticlePloS one2014

Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.

Sanjana Dayal, Ilya O Blokhin, Rochelle A Erger, Melissa Jensen, Erland Arning, Jeff W Stevens, Teodoro Bottiglieri, Frank M Faraci, Steven R Lentz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Cardioprotective Effects of Remote Ischemic Conditioning in a Rat Model of Acute Myocardial Infarction.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  7. Article
  8. Microvascular Dysfunction and Cognitive Impairment.Cellular and molecular neurobiology · 2016
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sanjana DayalDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
Ilya O BlokhinDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Interdisciplinary Graduate Program in Molecular and Cellular Biology, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
Rochelle A ErgerDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Veterans Affairs Medical Center, Iowa City, Iowa, United States of America.
Melissa JensenDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
Erland ArningBaylor Institute of Metabolic Disease, Dallas, Texas, United States of America.
Jeff W StevensDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
Teodoro BottiglieriBaylor Institute of Metabolic Disease, Dallas, Texas, United States of America.
Frank M FaraciDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Francois M. Abboud Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
Steven R LentzDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
University of Iowa · USVeterans Health Administration · US

Funding

Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2000 to 2015
$22.2M
Vascular Mechanisms in Homocysteinemia and AtherosclerosisR01HL063943 · NHLBI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2000 to 2012
$4.0M
BLRD VA I01 BX001399NHLBI NIH HHS HL062984NHLBI NIH HHS HL063943NHLBI NIH HHS P01 HL062984NHLBI NIH HHS R01 HL063943
6 · The paper itself

Abstract

Diet-induced hyperhomocysteinemia produces endothelial and cardiac dysfunction and promotes thrombosis through a mechanism proposed to involve oxidative stress. Inducible nitric oxide synthase (iNOS) is upregulated in hyperhomocysteinemia and can generate superoxide. We therefore tested the hypothesis that iNOS mediates the adverse oxidative, vascular, thrombotic, and cardiac effects of hyperhomocysteinemia. Mice deficient in iNOS (Nos2-/-) and their wild-type (Nos2+/+) littermates were fed a high methionine/low folate (HM/LF) diet to induce mild hyperhomocysteinemia, with a 2-fold increase in plasma total homocysteine (P<0.001 vs. control diet). Hyperhomocysteinemic Nos2+/+ mice exhibited endothelial dysfunction in cerebral arterioles, with impaired dilatation to acetylcholine but not nitroprusside, and enhanced susceptibility to carotid artery thrombosis, with shortened times to occlusion following photochemical injury (P<0.05 vs. control diet). Nos2-/- mice had decreased rather than increased dilatation responses to acetylcholine (P<0.05 vs. Nos2+/+ mice). Nos2-/- mice fed control diet also exhibited shortened times to thrombotic occlusion (P<0.05 vs. Nos2+/+ mice), and iNOS deficiency failed to protect from endothelial dysfunction or accelerated thrombosis in mice with hyperhomocysteinemia. Deficiency of iNOS did not alter myocardial infarct size in mice fed the control diet but significantly increased infarct size and cardiac superoxide production in mice fed the HM/LF diet (P<0.05 vs. Nos2+/+ mice). These findings suggest that endogenous iNOS protects from, rather than exacerbates, endothelial dysfunction, thrombosis, and hyperhomocysteinemia-associated myocardial ischemia-reperfusion injury. In the setting of mild hyperhomocysteinemia, iNOS functions to blunt cardiac oxidative stress rather than functioning as a source of superoxide.

Indexed as

AnimalsCerebral ArteriesDietDisease Models, AnimalEndothelium, VascularFemaleHomocysteineHyperhomocysteinemiaMaleMethionineMiceMice, KnockoutMyocardial Reperfusion InjuryMyocardiumNitric Oxide Synthase Type IIPhenotypeHomocysteineMethionineNitric Oxide Synthase Type IIReactive Oxygen SpeciesVasodilator Agents

Identifiers

PMID25226386
PMCPMC4167199
OpenAlexW2055984302

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.